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Abstract
Background: Analyzing process and outcome measures for all patients diagnosed with an infection in a hospital, including
those suspected of having an infection, requires not only processing of large datasets but also accounting for numerous patient
parameters and guidelines. Substantial technical expertise is required to conduct such rapid, reproducible, and adaptable analyses;
however, such analyses can yield valuable insights for infection management and antimicrobial stewardship (AMS) teams.
Objective: The aim of this study was to present the design, development, and testing of RadaR (Rapid analysis of diagnostic
and antimicrobial patterns in R), a software app for infection management, and to ascertain whether RadaR can facilitate
user-friendly, intuitive, and interactive analyses of large datasets in the absence of prior in-depth software or programming
knowledge.
Methods: RadaR was built in the open-source programming language R, using Shiny, an additional package to implement
Web-app frameworks in R. It was developed in the context of a 1339-bed academic tertiary referral hospital to handle data of
more than 180,000 admissions.
Results: RadaR enabled visualization of analytical graphs and statistical summaries in a rapid and interactive manner. It allowed
users to filter patient groups by 17 different criteria and investigate antimicrobial use, microbiological diagnostic use and results
including antimicrobial resistance, and outcome in length of stay. Furthermore, with RadaR, results can be stratified and grouped
to compare defined patient groups on the basis of individual patient features.
Conclusions: AMS teams can use RadaR to identify areas within their institutions that might benefit from increased support
and targeted interventions. It can be used for the assessment of diagnostic and therapeutic procedures and for visualizing and
communicating analyses. RadaR demonstrated the feasibility of developing software tools for use in infection management and
for AMS teams in an open-source approach, thus making it free to use and adaptable to different settings.
(J Med Internet Res 2019;21(6):e12843)   doi:10.2196/12843
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With antimicrobial resistance (AMR) on the rise, efforts are
being made worldwide to focus on the preservation of
antimicrobials as a precious nonrenewable resource. Infection
management in the form of antimicrobial stewardship (AMS)
programs has emerged as an effective solution to address this
global health problem in hospitals. AMS programs are defined
as “a coherent set of actions which promote using antimicrobials
responsibly” [1]. Stewardship interventions and activities focus
on individual patients (personalized medicine and consulting)
as well as patient groups or clinical syndromes (guidelines,
protocols, information technology infrastructure, and clinical
decision support systems) while prioritizing improvement in
quality of care and patient safety for any intervention. The
appropriate use of antimicrobials based on accurate and timely
diagnostics is integral for the successful management of
infections. In doing so, the diagnostics contribute to efforts in
minimizing AMR by optimizing the use of antimicrobials.
AMS setups in hospitals are often heterogeneous, but audit and
feedback to assess the goals are essential parts of most programs,
and they are included in international guidelines and reviews
[2-7]. Important data for AMS programs include, for example,
days of therapy (DOT), daily defined doses (DDD), admission
dates, length of stay (LOS), and adherence to local or national
diagnostic, therapeutic, or infection management guidelines [1].
Clinical outcomes, quality of care, or consumption of hospital
resources can be measured, for example, using mortality data
or surrogate parameters such as LOS. The collection of these
data is facilitated by electronic health records (EHRs) and
administrative local databases. Notably, administrative data
have also been shown to be a reliable source for assessing
clinical outcomes [8].
EHRs usually offer quick insights into useful infection
management data on the individual patient level. However, easy
access to analyze patient groups (eg, stratified by departments
or wards, specific antimicrobials, or diagnostic procedures used)
is difficult to implement in daily practice. It is even more
challenging to rapidly analyze larger patient populations (eg,
spread over multiple specialties) even though this information
might be available. Nevertheless, this is vital for meaningful
analysis, including possible confounders and pattern recognition
across different populations. Moreover, when aggregated data
are available, it is often not possible to trace individual patients,
and analyses lack the ability to be further adjusted or stratified.
AMS teams are multidisciplinary, and they act beyond the
borders of single specialties [9]. They are usually understaffed,
with limited data analysis support [10,11]. Therefore, they need
user-friendly and time-saving data analysis resources, without
the need for profound technical expertise once the system is set
up. Aggregating and linking data of antimicrobial use, guideline
adherence, and clinical outcomes at the institutional level can
build the basis for important insights for these teams. These
could be used to identify areas within hospitals that might benefit
most from supportive AMS interventions (eg, subspecialties
with lower guideline adherence or unusual patterns of
antimicrobial use). Moreover, feedback from these data could
help physicians better understand their patient population as a
whole; in addition, hospital administration could allocate
resources in a more targeted fashion.
Furthermore, aggregated data and simultaneous analysis of
multiple areas (eg, use of diagnostics and antimicrobials) present
an extensive insight into large patient populations. This also
enables the development of comprehensive and multidisciplinary
approaches of infection management, combining diagnostic and
therapeutic perspectives [1,9,12]. Unfortunately, these kinds of
analyses still require substantial statistical knowledge and
software skills, and it is time consuming when performed.
Technology, data science, and software app development can
bring solutions to complex data handling problems such as those
described above. Software app development for medical and
epidemiological (research) questions has found many important
answers during recent years. For example, software apps at
hospital emergency departments (EDs) in the form of a
dashboard have been shown to improve efficiency and quality
of care for patients requiring emergency admission to hospital
[13]. These software apps are used to communicate clearly
defined clinical problems, such as mortality ratio, number of
cardiac arrests, or readmission rate to the EDs. This has led to
a decreased LOS and mortality at the EDs. Others used similar
approaches to rapidly and interactively display geographical
locations of tuberculosis cases without the need of technical
expertise improving the understanding of transmission and
detection [14]. Furthermore, data-driven fields such as genomics
are front runners in developing new, innovative software apps
to handle large datasets, in close collaboration with
bioinformatics [15]
It is important to note that all of these abovementioned software
apps have been created in an open-source approach. This means
that the underlying source code can be easily shared, easily
modified, and freely distributed through open repositories, such
as GitHub [16], taking open-source software license obligations
into account. This facilitates collaboration, quality control
through code review, and easy adaptation to many different
settings and information technology systems, and this supports
the use of advanced data visualization for users with minimal
experience in programming and little or no budget for
professional database engineers [15].
In the field of medical microbiology, different approaches have
been described to interactively work with microbiological
diagnostics data and EHRs: electronic antibiograms, centralized
resistance analysis, EHR data mining, and clinical decision
support systems for AMS are great examples for innovation in
the field [17-19]. However, a full open-source approach for
software apps working with combined antimicrobials use and
diagnostic data of individual patients on the hospital level in
the field of infection management is still lacking.
Objectives
We followed principles of open knowledge [20] to address the
need for an interactive, easy-to-use software app that allows
users to investigate antimicrobial use, microbiological diagnostic
use, and patient outcomes at an institutional (hospital) level.
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We developed an open-source, Web-based software app—Rapid
analysis of diagnostic and antimicrobial patterns in R (RadaR)
that can be used for AMS and infection management. This free
software app can be run on regular computers or implemented
on local or Web-based servers to be accessed through standard
Web browsers. The focus user group of this software app is
health care professionals involved in AMS (eg, infectious
disease specialists, clinical microbiologists, and pharmacists).
Although some technical expertise (basic R knowledge) is
needed for installation and implementation, the use of RadaR
follows usual Web browser user experiences. RadaR enables
rapid and reproducible data analysis without extensive previous
analysis expertise in a graphically appealing way while being
adaptable to different settings. RadaR’s analyses are based on
datasets of individual patients. Therefore, aggregated results
can also be stripped down, and additional patient features can
be investigated. With this software app, we aim at supporting
data-driven hospital insights and decision making for actors in
the field of AMS in a free, transparent, and reproducible way.
Methods
For the development of software in an open-source environment,
we used the open-source programming language R in
conjunction with RStudio version 1.1.463 (RStudio, Inc) [21],
an open-source integrated desktop environment for R [22]. Both
R and RStudio are free of charge, and they need to be installed
for the development and implementation of RadaR. To build
RadaR as a Web-based software app, we used the Shiny package
for R [23]. Shiny allows R users to build interactive Web apps
without extensive knowledge in Web design and its
programming languages. The Web apps can be run and hosted
on the Web for free [24], as well as on local or cloud-based
servers or on personal computers.
The functionality of R can be easily extended by installing
additional packages. All packages used for the development of
RadaR are listed in Table 1. RadaR is developed in an
open-source environment and licensed under GNU General
Public License v2.0 [25], giving options to change, modify, and
adapt RadaR to both personal and commercial users’ needs
while requiring the need to document code changes [25].
RadaR’s calculations and data aggregation are done reactively
on the basis of the selection of the user. Single observations on
the patient level build the basis for any calculation. RadaR uses
common CSV files as input. A total of 3 different data sources
are read in RadaR for admission, antimicrobial, and
microbiological data, which are merged and transformed upon
start. A patient number or study number is used as a unique
identifier. All antimicrobial and microbiological data are
checked to ascertain whether they fall in the interval of
admission dates.
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Patient ID or study IDid






Fifth level of the World Health Organization Anatomical Therapeutic Chemical (WHO ATC)
classification systemb
atc_code
Defined daily dose of antimicrobial according to WHO ATC classification system per daybddd_per_day
Patient ID or study IDid
Microbiological data
Several columns of tested antimicrobial agents (eg, amoxicillin, ciprofloxacin) with resistance
results (R/I/S)
antimicrobial susceptibility testing
Patient ID or study IDid
Test materialmaterial




bAs available on the website [31].
cAs defined by the AMR package for R [30].
The input data should be structured in a dataset format, where
each variable is 1 column and each observation is 1 row. This
follows the concept of “tidy data,” as defined by Hadley
Wickham [26]. Table 2 displays the set of variables underlying
RadaR’s functionality. In our setting for the development of
RadaR, these variables originated from 3 different data sources:
administrative data from the hospital data warehouse,
microbiological data from the laboratory information system,
and antimicrobial prescription data from the computerized
prescriber order entry system. The data preparation and cleaning
process are very specific for each data source, dependent on
local data standards, and difficult to generalize. Therefore, Table
2 represents the final variables and formats for the analysis and
use with RadaR, referring to the “tidy data” concept above and
to the tidyverse R package collection for the preparation process
[26,27]. Additional variables are calculated and transformed
using the packages lubridate and zoo for time points and
intervals, and AMR for antimicrobial (group) names, microbial
isolate names, first isolate identification, and resistance analysis
[28-30]. Microbiological resistance is calculated per
antimicrobial substance or as coresistance if more than 1
substance is selected.
RadaR can be used for graphical exploratory data analysis.
Differences in LOS are displayed by a Kaplan-Meier curve in
conjunction with a log-rank test, using the survminer package
[32]. Time trends for number of admissions, antimicrobial
consumption, and resistance counts per year, quarter, or month,
are visualized in run charts using the qicharts2 package [33].
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Nonrandom variation in these run charts is tested using Anhøj’s
rules [34].
RadaR has been developed in macOS High Sierra (1.4 GHz, 4
GB RAM), and it was successfully tested in Windows 7 (3.2
GHz, 8 GB RAM) and Linux (Ubuntu 16.04.4 LTS, 3.4 GHz,
12 GB RAM). A running example version has been deployed
to shinyapps.io, a publicly available Web hosting service for R
Shiny apps [35]. The entire source code of RadaR is freely
accessible on GitHub [36]. We intend to integrate suggestions
and feedback coming from its users and the R community.
RadaR was developed using data of patients admitted to the
University Medical Center Groningen, Groningen, the
Netherlands. Data were collected retrospectively, and permission
was granted by the ethical committee (METc 2014/530). RadaR
can be used locally in protected environments or hosted on the
Web, provided appropriate measures have been taken to
guarantee data protection, depending on national regulations.
Results
Overview
We have developed RadaR, a Web-based software app providing
an intuitive platform for rapid analysis of large datasets
containing information about patients’ admission, antimicrobial
use, and results of microbiological diagnostic tests. This software
app can help users (ie, AMS team members) find answers to
questions, such as “What are the most commonly used
antimicrobials at an institution/specialty/department and have
they changed over time?,” “Were adequate microbiological
diagnostics performed at the start of antimicrobial treatments?,”
“What are the most frequent microorganisms found and their
resistance patterns in different departments?,” and “Can we
identify priority areas within a hospital where antimicrobial or
microbiological diagnostic use has the largest room for
improvement?”
Application Design
RadaR is designed in the form of a Web browser–based
dashboard that most users are familiar with from typical websites
and Web-based tools (see Figure 1). The basis of RadaR’s
functionality is filtering datasets and producing analytical graphs
according to selection criteria defined by the user. Any
calculations and data aggregation are based on single
observations of individual patients. To identify and analyze
groups of patients, 17 different selection criteria can be found
in the sidebar (Table 3). The output of RadaR is grouped into
4 panels (patient, antimicrobials, diagnostics, and outcome) that
each comprise 3 to 4 output boxes displaying the results (see
Multimedia Appendix 1).
All output is based on the selection criteria defined by the user
in the sidebar. Each new selection and any change need to be
confirmed by clicking the confirm selection button (see Figure
1). Users can navigate among the different analysis panels by
clicking the respective button.
Figure 1. Application design.
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Table 3. Selection criteria in sidebar.
FunctionalityTab name and criteria
Antimicrobials
Select patients starting treatment in a defined time periodStart of antimicrobials (in relation to start of admission)
Select patients with a minimum treatment durationMinimum duration of treatment (days)—all antimicrobials
Define the minimum duration of a prescription for any selected antimicrobialMinimum duration of prescription (days)—single antimicrobial
Intravenous or oralAdministration route
Filter patients for first prescribed antimicrobial only or any (on the basis of
all other selection criteria)
First antimicrobial only
Fourth level of the World Health Organization Anatomical Therapeutic
Chemical (WHO ATC) classification systema
Groups of antimicrobials
Fifth level of the WHO ATC classification systemaAntimicrobials
Patients
Female or maleGender
As available in the dataAge
Year
Years available in the dataYear
Specialty
Internal medicine, surgery, or otherSpecialty
0, 10, 100, 1000, or 10,000Minimum number of patients per subspecialty
All other subspecialties will be excludedInclude only this subspecialty
Define single subspecialties to be excludedExclude subspecialty
Origin
As available in the dataOrigin at admission
Diagnostics
Blood culture or urine culture testType of diagnostics
Define time period for tests to be performed inDays to first test (in relation to start of antimicrobials)
aAs available on the website [31].
Results are shown in bar charts, density plots, run charts, a
bubble plot, and a Kaplan-Meier curve for LOS in hospital.
Each panel further displays a table summarizing the respective
data analyses. All output boxes and their content are described
in Table 4. Most output boxes include modification options that
can be identified by small gear icons (see Figure 1). These
clickable icons allow for further specification of the generated
plots and tables. Users can compare different groups (eg,
antimicrobial use by antimicrobial agent, resistance patterns per
isolate, or LOS by specialty) or modify the plots (eg, switch
from count to proportion, change the chart type, or show or hide
the legend). Plots and tables can be downloaded through
download buttons as PNG files for plots and CSV, Excel, or
PDF files for tables.
Finally, 2 datasets (antimicrobial/admission data and
microbiological data) of the user-defined selection can be
downloaded from the sidebar menu in a CSV-file format for
further analysis (eg, retrieving a list of patient numbers of the
selected patient group).
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Table 4. Output boxes for analysis results.
Modification optionsContentOutput typeOutput panel and output box
Patients
Show top 10 by number of patientsPatients per subspecialtyBubble
charta
Subspecialties in selection
—bTotal number of patients and per sub-
specialty
TableSubspecialties—table
Group by genderAge distribution in selectionDensity plot
(distribution)
Patient age
Per year, per quarter, or per monthCount of admissions per time periodRun chartNumber of admissions
Antimicrobials
Single antimicrobials or groups; select prescription
count, DDD, or DOT per 100 bed days
(Group of) antimicrobials sorted by
prescription, DDDc, or DOTd
Bar chartAntimicrobials
Group by none, specialty, subspecialty, and origin; per
year, per quarter, and per month
DDD per 100 bed days per group and
per time period
Run chartDDD
Group by none, specialty, subspecialty, and origin; per
year, per quarter, and per month
DOT per 100 bed days per group and
per time period
Run chartDOT
DDD or DOT per 100 bed days; group by antimicrobial
(group), year, specialty, subspecialty, and origin




Count or proportion; per year, quarter, or monthDiagnostics taken versus not taken in
specified timespan
Bar chartDiagnostics in selected patients
—bTime of diagnostics performed in days
after start of treatment
Bar chartTiming of selected diagnostics
Group by antimicrobial (group), year, specialty, subspe-
cialty, and origin
Absolute difference from average pro-
portion of selected diagnostics per-
formed
Bar chartDiagnostics in relation
Group by antimicrobial (group), year, specialty, subspe-
cialty, and origin
Summary of proportion of diagnostics
performed
TableTable—proportion performed
Group by antimicrobial (group), year, specialty, subspe-
cialty, and origin; zoom to select more or less isolates
shown in graph
First isolates of microorganisms sorted
by frequency
Bar chartFirst isolates in selected diag-
nostics
Group by year, specialty, subspecialty, and originFrequency table of first isolatesTableFirst isolates—table
Select isolates; select antimicrobials; group by year,
specialty, subspecialty, and origin; select count or pro-
portion
Count or proportion of resistance or
coresistance to selected antimicrobials
in selected isolates in “R,” “S,” and “I”
categories
Bar chartResistance analysis
Select isolates; select antimicrobials; per year, per
quarter, or per month
Count of resistance or coresistance to
selected antimicrobials in selected iso-
lates in “R,” “S,” and “I” categories
over time
Run chartResistance—over time
Group by year, month, quarter, specialty, subspecialty,
and origin; select isolates; select antimicrobials; select
count or proportion
Count or proportion of resistance or
coresistance to selected antimicrobials




Group by all, gender, year, antimicrobial (group), diag-
nostics performed, specialty, subspecialty, and origin;
Distribution of length of stay per groupDensity plot
or histogram
Length of stay
show histogram; show legend; spread out to remove
overlaps
Groups shown as selected in the length-of-stay boxKaplan-Meier curve per groupKaplan-
Meier curve
Length of stay—Kaplan-Meier
Group by gender, year, antimicrobial (group), diagnos-
tics performed, specialty, subspecialty, and origin
Summary of length of stay per groupTableLength of stay—table
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aInteractive plot showing additional information when hovering over plot.
bNot applicable.
cDDD: defined daily doses.
dDOT: days of therapy.
Development Process
RadaR has been developed in close contact with the AMS team
and senior consulting specialists at the University Medical
Center Groningen, Groningen, the Netherlands, to meet the
needs and requirements of this user group. Subsequently, all
members of the European Society of Clinical Microbiology and
Infectious Diseases Study Group for Antimicrobial Stewardship
(ESGAP) were asked to evaluate and test the software app
through a running Web-based example of RadaR and by filling
out a Web-based survey. The ESGAP comprises around 200
members from more than 30 countries worldwide. A total of 12
members from 9 different countries took part in the evaluation.
This yielded important information on user experiences with
the software app, which in turn led to further improvements that
are reflected in the version we presented in this report. In a next
phase, RadaR will be tested in different settings of ESGAP
members and other interested partners using locally available
data (eg, an 837-bed tertiary care hospital in the Netherlands
and a 750-bed tertiary care hospital in Greece).
Workflow
RadaR was developed and tested with a dataset of all patients
admitted to our institution, a 1339-bed academic tertiary referral
hospital, within the years of 2009 to 2016, comprising over
180,000 admissions. For simulation purposes and Web-based
user testing, we have created a test dataset of 60,000 simulated
patients. This sample dataset allows testing of RadaR’s
functionality, but it does not produce meaningful results.
A typical example workflow with RadaR comprises 6 steps
(with examples from the test dataset). They are listed below:
1. Define the selection: For example, patients receiving
intravenous second- or third-generation cephalosporins as
first treatment for at least 2 days, starting within the first 2
days of hospital admission from any specialty in all years
in the dataset.
2. Patients’ panel: Identify the total number of patients and
the subspecialties with the highest number of included
patients (eg, 537 patients selected in total, with 97 patients
from internal medicine). Investigate patients’ gender and
age distribution.
3. Antimicrobials panel: Identify the total use of the initial
cefuroxime treatment in DDD and DOT per 100 bed days
(eg, 4.51 and 1.5, respectively). Stratify the results by
subspecialty and identify the highest number of DDD and
DOT per 100 bed days (eg, highest use by DDD and DOT
in internal medicine).
4. Diagnostics panel: Check if the selected microbiological
diagnostic test (eg, blood culture test) has been performed
on the same day as the start of the treatment (defined in the
sidebar). Investigate the proportion of tests performed over
the years and investigate which subspecialty performs best
compared with others (eg, Pediatrics). Check which
microorganisms (as first isolates) were found in the selected
diagnostic specimens (the most common isolate:
Escherichia coli). Investigate the proportion of isolates
resistant to cefuroxime (8.9%) and analyze the trend over
time.
5. Outcome panel: Check for patterns of differences in LOS
in the defined patient group by subspecialties or performed
diagnostics (eg, highest mean LOS of 7.8 days in Surgery).
6. Refine the selection: Investigate a subgroup of the original
selection. For example, select only the top 3 subspecialties
by number of patients and repeat step 2 to 5.
Customization
For setting up RadaR in a new environment after data
preparation, users only need to perform the following 4 steps:
1. Downloading R and RStudio [21,22], which are free to use
and open-source software
2. Download or copy and paste RadaR’s source code [36] into
3 files in RStudio—global.R, server.R, and ui.R
3. In global.R, manually edit the paths for the prepared datasets
to be imported into RadaR
4. Run the app in RStudio with the calling the function
runApp() in the console or by clicking the green run app
button. This will download and install the required R
packages needed for the app if they have not been installed
previously, and this will create the final dataset for analysis.
The RadaR interface will open in the RStudio viewer pane
or in a new window of the standard browser of the user’s
operating system.
RadaR’s appearance has been customized using a cascading
style sheets (CSS) script [37] that is loaded into the app upon
its start. This script needs to be saved into a subdirectory of the
directory of the 3 main files (global.R, server.R, and ui.R) called
“www.” We recommend RStudio’s project function to create a
single project for RadaR and to store all information in this
project directory. Users with experience in using CSS can fully
alter RadaR’s design by changing the underlying CSS script.
Discussion
Principal Findings
We have developed a Web-based software app for rapid analysis
of diagnostic and antimicrobial patterns that can support AMS
teams to tailor their interventions. It has been designed to
enhance communication of relevant findings while being easy
to use. This also applies to users without extensive prior software
skills, as it follows usual Web browser user experiences.
Moreover, it has been developed using open-source software.
It is therefore free to use and accessible for download. In our
experience, this system can be adapted to new settings within
1 day, when the required data (Table 2) are available.
Commercial software for infection management is available
(eg, Epic Antimicrobial Stewardship Module, TREAT Steward).
These offer extensive options for filtering, analyzing, and
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visualizing EHRs with real-time connections to hospital data
infrastructures and have been shown to be useful in clinical
practice [38]. However, it is difficult to compare functionalities
of these tools because of their non–open-source nature. This
fact, along with the required budget to purchase the software,
drastically limits their use. We are convinced that transparent
software development can support the adoption of data-driven
developments while enhancing optimal quality of care and
patient safety, which is crucial in the light of new data-driven
developments of using EHRs [39,40].
The global nature of infections further calls to develop software
tools applicable in resource-limited settings [41]. Open-source
approaches for data analysis, such as RadaR, have advantages
over traditional methods, such as Excel or SPSS. Hughes et al
described those in their report of a software app for
RNA-sequencing data analysis [15]. They highlight aspects that
were also fundamental for the development of RadaR. First, R
allows transparent, reproducible, and sustainable data analysis
through scripts that can easily be shared and changed. This can
build the basis for collaboration, and this enforces the spirit of
open science (also through the strong collaborative R community
on the Web). Second, R is open source and free to use; therefore,
it also enables use in resource-limited settings. Finally, Shiny
empowers users to interact with the data, making even very
large datasets quickly interpretable.
Innovative approaches used in supporting infection management
by leveraging EHRs are being investigated [17-19]. Reporting
on AMR, antimicrobial use, and hospital infections (eg, for
quality assurance) is well established, but it is important to
integrate these data sources in an approach that allows detailed
filtering options on all input. Merely looking at antimicrobial
use alone or comparing aggregated results (eg, total amount of
a specific antimicrobial substance per hospital correlated with
the total count of a resistant isolate) will result in loss of
information or even misleading interpretation. Detailed data
and calculations on the basis of each individual patient are
crucial to draw informed conclusions. Unfortunately, the
abovementioned infection management approaches [17-19]
either depend on additional commercial software for data
visualization or the source code is not openly available. We
want to encourage others to turn toward available open-source
software solutions, such as R, for an increased potential of
collaboration and transparency. However, their strength is the
connection to real-time data flows. This enables the prospective
use and increases their usability for daily clinical practice.
RadaR is currently still limited to retrospective data analysis
because of a changing hospital data infrastructure in our setting.
Technically, it is feasible to connect R-based software apps such
as RadaR to real-time hospital data infrastructures running with
clinical data standards [42]. For a start, access to static data
extraction is often easier and faster to achieve. RadaR can be
used to advocate the use of data visualization tools and improved
accessibility of hospital data sources. Until connection to
real-time hospital data is established, RadaR can support users
as a stand-alone option for retrospective data analysis in
infection management. Next steps will involve testing in
multiple settings and forming a user and research group to
continue and expand the use of open-source technology and
open science principles in infection management.
Conclusions
RadaR demonstrates the feasibility of developing software tools
for infection management and AMS teams in an open-source
approach, making it free to use, share, or modify according to
various needs in different settings. RadaR has the potential to
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DOT: days of therapy
EDs: emergency departments
EHR: electronic health record
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LOS: length of stay
RadaR: Rapid analysis of diagnostic and antimicrobial patterns in R
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